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Importins mediate transport from synapse to soma
and from cytoplasm to nucleus, suggesting that
perturbationof importin-dependent pathwaysshould
have significant neuronal consequences. A behav-
ioral screenonfive importinaknockout lines revealed
that reduced expression of importin a5 (KPNA1) in
hippocampal neurons specifically decreases anxiety
in mice. Re-expression of importin a5 in ventral hip-
pocampus of knockout animals increased anxiety
behaviors to wild-type levels. Hippocampal neurons
lacking importin a5 reveal changes in presynaptic
plasticity and modified expression of MeCP2-
regulated genes, including sphingosine kinase 1
(Sphk1). Knockout of importin a5, but not importin
a3 or a4, reduces MeCP2 nuclear localization in
hippocampal neurons. A Sphk1 blocker reverses
anxiolysis in the importin a5 knockout mouse, while
pharmacological activation of sphingosine signaling
has robust anxiolytic effects in wild-type animals.
Thus, importin a5 influences sphingosine-sensitive
anxiety pathways by regulating MeCP2 nuclear
import in hippocampal neurons.INTRODUCTION
Anxiety and stress-related conditions are a significant health
burden in modern society. Pharmacological interventions have
implicated several hormones and neurotransmitters in anxiety
modulation (Dias et al., 2013; Griebel and Holmes, 2013), but
intracellular transport systems have not been studied in this
context. Coupling neurotransmitter signals to behavioral output
likely requires changes in transcription in neurons (West and
Greenberg, 2011), necessitating information transfer from syn-
apse to nucleus (Herbst and Martin, 2017; Lim et al., 2017; Saito
and Cavalli, 2016). Members of the importin family of nuclearCell Repor
This is an open access article under the CC BY-Nimport factors have pivotal roles in such pathways because
of their involvement in intracellular transport between synapse
and soma (Panayotis et al., 2015) and between cytoplasm and
nucleus (Miyamoto et al., 2016). However, importins and related
molecules have not been studied for potential roles in anxiety
regulation to date.
Nuclear import factors from the importin a subfamily directly
bind nuclear localization signals (NLSs) in cargo proteins in
cooperation with importin b1. There are 6–7 importin a family
members in any given mammal (Table S1), and individual cell
types express different subsets of this ensemble (Pumroy
and Cingolani, 2015), often in a tightly regulated manner (Yasu-
hara et al., 2007, 2013). Injury in peripheral neurons (Ben-Yaakov
et al., 2012; Hanz et al., 2003; Perry et al., 2012; Terenzio et al.,
2018; Yudin et al., 2008) or activity in central neurons (Ch’ng
et al., 2012; Dieterich et al., 2008; Jeffrey et al., 2009; Karpova
et al., 2013; Thompson et al., 2004) can activate importin-depen-
dent transport mechanisms in axons or dendrites to link both
pre- and postsynaptic compartments to soma and nucleus
(Lim et al., 2017; Rishal and Fainzilber, 2014). Assigning specific
roles for individual importin a’s in brain functions is challenging
due to functional redundancies in cargo binding (Friedrich
et al., 2006; Ushijima et al., 2005) and compensatory expression
regulation of different family members (Shmidt et al., 2007). We
addressed this issue by subjecting five importin a knockout
(KO) mouse lines to a comprehensive battery of behavioral tests.
Of the five lines analyzed, comprising single-gene knockouts for
importin a1, a3, a4, a5, and a7 (Gabriel et al., 2011; Rother et al.,
2011; Shmidt et al., 2007), the importin a5 knockout was the only
line to reveal significantly reduced anxiety phenotypes. The mo-
lecular mechanism underlying importin a5-dependent anxiolysis
is elucidated here.RESULTS
An Anxiolytic Phenotype in Importin a5 Knockout Mice
Behavioral phenotyping was performed on five single-gene
importin a knockout mouse lines, all of which were viable
and reached adulthood. We used a panel of assays to followts 25, 3169–3179, December 11, 2018 ª 2018 The Author(s). 3169
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. Behavioral Phenotyping of
Different Importin a Knockout Mice
The tests used cover (A) general locomotion and
circadian activity, (B) novelty-induced locomotion,
and (C) anxiety-related behaviors.
(A) Basal home-cage activity of the mice in a
home-cage locomotion test. An InfraMot system
was used to monitor the activity of the mice
over 72 consecutive hours. Most importin
a-knockout mouse lines do not exhibit significant
modification of their activity during dark or light
periods (a1, a4, a5, and a7; p > 0.05). Importin a3
knockouts showed elevated activity compared to
wild-type during the dark phase (148% ± 11.9%;
p < 0.05) and decreased activity during the light
phase (66.03% ± 10.17%; p < 0.05).
(B) Novelty-induced locomotion was assessed in
an open-field test performed under dim light
(open-field-6 lux). No significant differences were
observed for all importin a mutants compared to
their wild-type littermates.
(C) Anxiety measures from the open-field test
(OF-120 lux) show an increased center-to-border
ratio for importin a5 null mice. In the elevated plus
maze, importin a5 mice travelled more in the open
(i.e., unsecured and anxiogenic) arms. Importin a5
null mice displayed a decreased baseline acoustic
startle, in accordance with a reduction in anxiety-
related behaviors in this line. Importin a3 results
indicatean increasedstartle response, and importin
a4 nulls present a deficit in the startle response.
8–15 animals were used for each line in the
different assays of this dataset. *p < 0.05, **p < 0.01,
***p < 0.001, ****p < 0.0001; two-tailed t test. All data
error bars representmean±SEM.SeealsoDataS1.home-cage locomotion and circadian activity, novelty-induced
locomotion, and anxiety behaviors (Figure 1; Data S1). Importin
a5 knockout animals displayed a specific phenotype character-
ized by reduced anxiety in multiple tests, including open field,
elevated plus maze, and acoustic startle response. Open-field
and elevated plus maze tests are based on the monitoring of
mouse locomotion activity when placed in a novel environment
offering both secure and anxiogenic areas (Prut and Belzung,
2003; Walf and Frye, 2007). In contrast, the acoustic startle
response monitors a reflex-based response to a sudden loud
sound (Koch, 1999). Importin a5 knockout mice explored and
reared significantly more than their wild-type littermates in the
central anxiogenic area of the open field (Figures 2A–2C). The
specificity of the result was confirmed by the absence of effects
on total distance traveled or velocity of movement, as well as
time spent in the open-field anxiogenic area under low illumina-
tion (6 lux, assessing general motor activity) (Trullas and Skol-
nick, 1993), ruling out possible general movement phenotypes
in these mice (Figure S1A).
In line with the open-field results, importin a5 knockout mice
showed a significant increase in distance covered, time spent,
and number of visits in the open arms of the elevated plus
maze compared to their wild-type littermates (Figures 2D–2F;
Figure S1B). We examined their anxiety responses in an acoustic
startle response test, monitoring the involuntary motor reflex to a
loud auditory stimulation of 120 dB. Importin a5 knockout mice3170 Cell Reports 25, 3169–3179, December 11, 2018exhibited both a significant increase in reaction time and a signif-
icantly reduced response amplitude compared to wild-type
littermates (Figures 2G–2I). The importin a5 knockout was the
only line of the five importin a mutants tested that revealed a
consistent phenotype in all three anxiety tests, emphasizing
the robustness of the findings. Moreover, importin a5 knockout
animals did not reveal differences in home-cage activity or per-
formance in rotarod, wire hanging, and pole tests (Figures
S1C–S1F). Learning and memory features of the importin a5
knockouts were assessed in Morris water maze (MWM) setups
(Figures S1G–S1M). Although there was an apparent lower per-
formance of the importin a5 knockout animals, the reduction in
time spent scanning for the escape platform (Figure S1J) was
not compensated by more sustained exploration of the other
quadrants (Figure S1K). Hence, these MWM data may also
reflect lower anxiety of the importin a5 knockouts, with less ur-
gency to escape the MWM than their wild-type counterparts.
Altogether, this battery of additional assays supports a specific
reduction in anxiety levels in importin a5 null mice, without
changes in other physiological parameters of overall motor
performance, coordination, or activity.
Anxiety-related responses are influenced by changes in synap-
tic plasticity, which are reflected in abnormal responses in the hip-
pocampus or the amygdala (Bannerman et al., 2014; Jimenez
et al., 2018; Tovote et al., 2015).We therefore assessed basal syn-
aptic transmission, presynaptic-dependent short-term plasticity,
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Figure 2. Reduced Anxiety in Importin a5 Knockout Mice
(A–C) Group heatmap representation (A) of mouse activity over 10 min in the open field. Importin a5 knockout mice exhibit significant increases in the time spent,
the distance traveled (B), and rearing activity (C) in the open-field center.
(D–F) Importin a5 knockoutmice show increased exploration of the open arms of an elevated plusmaze, as shown by representative track traces (D), significantly
higher distance coverage (E), and time spent (F) in the open arms compared to wild-type littermates.
(G–I) Results from an acoustic startle response test monitoring the motor reflex to 120 dB auditory stimulation. Importin a5 knockout mice revealed a significant
increase in reaction time (G) to the auditory stimulus (p < 0.05), a significant decrease in response amplitude (H), and a delay of the peak response (I) compared to
wild-type littermates.
nR 9 animals for each genotype per test. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001; one-way ANOVA followed by Tukey’s HSD post hoc correction for
multiple comparisons. All data error bars represent mean ± SEM. See also Figure S1.and long-term potentiation (LTP) at hippocampal Schaffer collat-
eral synapses (Figure 3; Figure S2). The most prominent effects
were observed in short-term synaptic plasticity associated with
paired-pulse facilitation (PPF) or paired-pulse depression (PPD),
revealing marked depression in importin a5 knockout slices, in
contrast to facilitation in wild-type, at all time points measured.
Overall, the data indicate a presynaptic deficit in importin a5
knockout hippocampus, suggesting differential regulation of syn-
aptic vesicle pools andpresynaptic calcium levels anddistribution
in themutantmice.Moreover, analysis of basal synaptic transmis-
sion revealed stronger excitability patterns in knockout and het-
erozygous mice versus wild-type, although the magnitude of the
field excitatory postsynaptic potential (fEPSP) slope at maximal
stimulation intensity was similar in all tested groups.
A Transcriptional Component in Importin a5-Dependent
Anxiolysis
We used the anxiogenic drug FG-7142 (Evans and Lowry, 2007)
to test whether the reduction in anxiety in importin a5 knockoutmice is amenable to pharmacological modulation. FG-7142
increases anxiety by a partial agonist effect on the g-aminobuty-
ric acid A (GABA-A) receptor (Figure 4A) and hence provides
a convenient tool to test whether anxiolysis in importin a5
knockout animals is hard wired or is reversible (Figure 4B). FG-
7142 reversed anxiolysis in importin a5 knockout animals in
open-field tests without affecting overall movement velocity in
the test (Figures 4C–4F). We then proceeded to analyze hippo-
campal transcriptomes by RNA sequencing (RNA-seq). RNA
was extracted from total hippocampi, which were dissected
from either importin a5 or wild-type (WT) animals injected with
vehicle or FG-7142. Analyses of the resulting datasets revealed
significant changes in the expression of 121 genes under basal
conditions in importin a5 null mice (Figures 5A and 5B) and a
larger cohort of almost 600 transcripts that were differentially
regulated by FG-7142 treatment in knockout versus wild-type
mice (Figures S3A and S3B; Table S2). We then performed
computational analyses of these differential groups to reveal
the underlying transcriptional networks, using the TRANSFACCell Reports 25, 3169–3179, December 11, 2018 3171
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Figure 3. Synaptic Effects of the Importin a5
Knockout
(A) Dependence of paired-pulse facilitation or
depression on the interval between two presyn-
aptic stimulations in hippocampal slice prepara-
tions. The paired-pulse facilitation or depression
is determined as a normalized increase or
decrease in the amplitude of the second
fEPSP, according to the following equation:
ðP2 P1Þ=P1, where P1 and P2 are the ampli-
tudes of the first and second fEPSPs, respectively.
In contrast to wild-type or heterozygous mice,
knockout slices revealed marked depression in
response to the paired-pulse protocol at all
measured time points.
(B) Raw data examples of paired fEPSP
responses acquired at presynaptic stimulation
interval of 50 ms from hippocampal slices from
all three genotypes (stimulation [stim], CA3;
recording, CA1).
(C) Post-tetanic potentiation (PTP) estimated as an
immediate increase of fEPSP slope after high-
frequency stimulation (HFS).
(D) The PTP decay time constant was found to be
significantly lower in a5 knockout mice. PTP The
decay time constant was derived using the expo-
nential decay function: fEPSP slope = fEPSP
slope max  eðt=tÞ + const:, where t is a time of
fEPSP recording and t is the fEPSP decay time
constant, representing the PTP decay time con-
stant. Theequationwasused tofit the normalized to
the baseline fEPSP slopes shown in (C).
(E) Normalized maximal fEPSP slope showing PTP magnitude was lowest in a5 knockout mice. Normalized maximal fEPSP slope was derived from the
exponential decay fit equation described in (D).
n = 5 WT (wild-type), 9 HET (heterozygous), and 7 knockout (a5 knockout) in each test. *p < 0.05, **p < 0.01, ***p < 0.001; one-way ANOVA with Holm-Sidak post
hoc analysis. See also Figure S2.FMatch promoter analysis tool, and the enriched pathways and
signaling networks, using the Ingenuity tool (Figure S3C). The re-
sulting list of transcription factors (TFs) that may control expres-
sion of importin a5 knockout differentially expressed genes
(DEGs) features several interesting candidates, most promi-
nently MeCP2 (Figure 5C), a transcriptional modulator best
known as the gene mutated in Rett syndrome (Lyst and Bird,
2015). MeCP2 gene dosage is known to affect anxiety behaviors
(Goffin et al., 2011; Na et al., 2012; Samaco et al., 2012; Stearns
et al., 2007). The Ingenuity pathway analyses (Figures S3C and
S3D) directed our attention to a lipid signaling network contain-
ing sphingosine kinase 1 (Sphk1), an MeCP2-regulated gene
(Figure 5C). The upregulation of Sphk1 in importin a5 knockout
hippocampus is intriguing, because previous studies have impli-
cated Sphk1, its product sphingosine 1 phosphate (S1P), and its
receptors in synaptic plasticity and presynaptic functions (Chan
and Sieburth, 2012; Kanno et al., 2010; Kempf et al., 2014).
Importin a5 Is Required for MeCP2 Nuclear Localization
in Hippocampal Neurons
Multiple nuclear import routes have been described for MeCP2
(Baker et al., 2015; Lyst et al., 2018); hence, we first assessed
MeCP2 interaction with importin a5 by fluorescence resonance
energy transfer (FRET) acceptor photobleaching. A significant
FRET signal was revealed in human embryonic kidney (HEK)3172 Cell Reports 25, 3169–3179, December 11, 2018cells cotransfected with MeCP2-GFP and importin a5-mScarlet
(Figures 5D and 5G), while no such signal was observed when
MeCP2-GFP was substituted by cytosolic GFP or phosphotries-
terase (PTE)-GFP constructs (Figures 5E–5G). We then per-
formed a series of immunofluorescence analyses to assess
MeCP2 expression and nuclear localization in the dorsal hippo-
campus (dHPC), the ventral hippocampus (vHPC), the amyg-
dala, and the motor cortex, comparing importin a5 knockouts
and their wild-type littermates. As shown in Figure 5H, MeCP2
localization was strictly nuclear and highly colocalized with
DAPI-positive heterochromatin in wild-type ventral hippocam-
pus neurons (90% colocalization) and ranged above 72% in all
other brain areas tested (Figure 5I; Figures S4A and S4B). In
contrast, importin a5 knockout brains revealed significant and
specific exclusion of MeCP2 from the nuclei of both ventral hip-
pocampus and dorsal hippocampus neurons (Figures 5H and 5I),
but not in amygdala or motor cortex (Figure 5I; Figures S4A
and S4B). There were no deficits in MeCP2 nuclear localization
in all brain regions examined from importin a3 and importin a4
knockout mice (Figures S4C–S4F).
To validate these findings by another approach, we evaluated
MeCP2 nuclear levels by western blot analyses of purified
nuclear fractions from ventral hippocampus and amygdala,
focusing on these regions due to their key roles in anxiety circuits
(Bannerman et al., 2014; Jimenez et al., 2018; Tovote et al.,
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Figure 4. Effects of the Anxiogenic Drug
FG-7142 on Wild-Type and Importin a5
Knockout Mice
(A) Schematic of the GABA-A receptor showing
the benzodiazepine binding site where FG-7142
acts as an inverse partial agonist.
(B) FG-7142 (5 mg/kg) or vehicle was injected
intraperitoneally, and its effects were assessed in
an open field after 30 min.
(C) Open-field activity heatmaps show that the
anxiolytic phenotype of importin a5 knockout mice
is reversed by FG-7142 treatment.
(D–F) FG-7142 treatment significantly decreases
the distance traveled in the center of the open field
(D) and the number of rearing events in the center
(E) but did not perturb the average movement
velocity (F).
The number of animals per group is indicated in
parentheses. *p < 0.05, **p < 0.01, ***p < 0.001;
one-way ANOVA followed by Tukey’s HSD post
hoc correction for multiple comparisons (D–F). All
data error bars represent mean ± SEM.2015). The analysis revealed a significant reduction of MeCP2
levels in nuclear extracts of importin a5 knockout ventral hippo-
campus, but not amygdala (Figures 5J and 5K). There were no
significant differences in MeCP2 levels in nuclear extracts from
either brain region from importin a3 or a4 mice (Figures 5J
and 5K), consistent with the immunofluorescence analyses
described earlier. Thus, importin a5 is critical for MeCP2 nuclear
localization in the ventral and dorsal hippocampus. The lack of
effect of single-gene importin knockouts in amygdala and motor
cortex may reflect different nuclear import routes for MeCP2 in
those neuronal subtypes.
Adult Ventral Hippocampus Importin a5 Knockdown
Reduces Anxiety Behaviors
We examined the role of importin a5 gene dosage in the ventral
hippocampus for anxiety behavior using virus-driven knock-
down by stereotaxic injection (Figures S5A and S5B). A short
hairpin RNA (shRNA) targeting murine importin a5 (sha5) was
validated for importin a5 knockdown in vivo, compared with a
shRNA scrambled sequence control (sh-scramble) (Figure S5C).
Three weeks after bilateral ventral hippocampus stereotaxic
injection of sha5 or sh-scramble, mice were evaluated in open-
field (OF), elevated plus maze (EPM), fear conditioning, and star-
tle response tests. Mice injected with either lentiviral or adeno-
associated virus serotype 5 (AAV5)-expressing sha5 showed
reduced anxiety in the open-field (Figures 6A–6D and 6H–6K)
and the elevated plus maze (Figures 6E–6G and 6L–6N) tests
compared to the corresponding sh-scramble controls. The
ventral hippocampus-injected importin a5 knockdown (KD)
mice did not show alteration in fear conditioning freezing or star-
tle responses (Figures S5D and S5E), suggesting no significantCell Reportsalterations in amygdala-dependent fear
memory or in pathways associated with
acoustic startle (Tovote et al., 2015). We
then sought to revert anxiety attenuation
in importin a5 knockdown mice byconcomitant expression of an sha5-resistant human importin
a5 expression construct. Importin a5 levels were preserved
upon coinjection of the human expression construct, together
with sha5 (Figure S5C), and anxiety-related behaviors did not
differ between coinjected mice and sh-scramble controls (Fig-
ures 6H–6N). Hence, acute and specific knockdown in the adult
ventral hippocampus confirms a role for hippocampal importin
a5 in regulation of anxiety.
Pharmacological Targeting of the Importin a5 Anxiolysis
Pathway
The data summarized earlier suggest that importin a5 regulates
anxiety through MeCP2 and sphingosine signaling pathways
(Figure 7A). Tissue-dependent expression of Sphk1 is controlled
by DNA methylation-dependent repression (Imamura et al.,
2004), and MeCP2 gene dosage can influence Sphk1 in the
mouse brain (Gabel et al., 2015). Removal of importin a5 reduces
MeCP2 levels in the nucleus, thereby enabling increased expres-
sion of Sphk1, followed by enhanced activation of S1P recep-
tors. This model predicts that S1P receptor agonists should
have anxiolytic effects, while Sphk1 antagonists should be
anxiogenic. Moreover, an effective Sphk1 antagonist should
attenuate the anxiolytic phenotype in importin a5 knockout
mice. We therefore tested the effects of two such molecules:
fingolimod, an S1P receptor agonist used as a drug in multiple
sclerosis (Chew et al., 2016), and PF-543, a selective inhibitor
of Sphk1 (Schnute et al., 2012).
We tested the effects of the S1P receptor agonist fingolimod
using a dose regime previously employed for trophic factor
studies in the hippocampus (Deogracias et al., 2012). Fingolimod
markedly reduced anxiety levels in both elevated plus maze25, 3169–3179, December 11, 2018 3173
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(Figures 7B–7D) and open-field assays (Figures S6A–S6C). We
repeated these assays on BALB/c mice, a line with intrinsically
higher anxiety levels than the C57BL/6 mice used thus far
throughout our study (Oliverio et al., 1973). Most strikingly,
BALB/c mice likewise exhibited significantly reduced anxiety
responses upon fingolimod treatment, despite their clearly
apparent higher basal anxiety measures (Figures 7E–7G; Figures
S6D–S6F). Finally, we tested the effects of the Sphk1 inhibitor
PF-543 by intraperitoneal (i.p.) injection in wild-type and importin
a5 knockout animals. Sphk1 inhibition did not influence anxiety-
related behavior of wild-type mice in the elevated plus maze.
However, it significantly decreased the distance traveled and
the time spent in the open arms for importin a5 knockout animals
(Figures 7H–7J). Hence, Sphk1 inhibition reverses the anxiety
reduction phenotype of importin a5 knockout mice as predicted.
DISCUSSION
Our findings highlight roles for importin a5 and MeCP2 in anxiety
regulation. Previous studies (Shmidt et al., 2007) and our own an-
alyses demonstrated normal brain development and a lack of
other behavioral abnormalities in the importin a5 knockout
mouse, emphasizing the specificity of the anxiety phenotype.
This specificity is most likely due to the requirement for importin
a5 for nuclear import of MeCP2 in certain neuronal subtypes,
including in the hippocampus. Patients suffering from Rett syn-
drome or from MeCP2 duplication syndrome present with anxi-
ety disorders as part of the clinical spectrum (Barnes et al.,
2015; Ramocki et al., 2009), and anxiety phenotypes have
been described for various MeCP2 mutant mouse models (Gof-
fin et al., 2011; Na et al., 2012; Samaco et al., 2008; Stearns et al.,
2007). Our data suggest that targeting importin a5 to reduce
MeCP2 nuclear import can attenuate anxiety, and it will be inter-
esting to test whether targeting importin a5 might ameliorate
other aspects of MeCP2-related diseases in the future.
The findings implicate the sphingosine signaling pathway
in importin a5/MeCP2-dependent anxiety regulation. Several
studies have linked sphingolipids to anxiety disorders, but the
mechanisms involved are not fully understood (M€uhle et al.,Figure 5. Transcriptional Effects of the Importin a5 Knockout Reveal a
(A) Volcano plot illustrating the gene expression results (top panel) and bar graph
a5 knockout hippocampus and the ratio of genes for which the levels of express
(B) Heatmap representation of Z score-transformed normalized expression value
hippocampus (n = 3 mice per group).
(C) Top 10 transcription factor candidates identified by an FMatch (geneXplain
importin a5 knockout. Genes regulated by MeCP2 are listed in the inset.
(D–F) Confocal images of HEK cells transfected with MeCP2-GFP and importin a
and importin a5-mScarlet (F). The images were taken before (pre) and after (po
delineating the cell (scale bar, 5 mm).
(G) Average FRET efficiency ± SEM (n of 9–17 cells per condition).
(H) Immunofluorescence for MECP2 (red) and DAPI nuclear staining (blue) revea
hippocampus (vHPC; CA3 region) of wild-type mice, with reduced colocalization
isosurface rendering of wild-type and a5 knockout nuclei (scale bar, 10 mm).
(I) Average Mander’s coefficient of colocalization quantified in the motor cortex, d
versus importin a5 knockout mice (nR 3 per genotype and structure).
(J and K) Immunoblots of MeCP2 and HDAC3 in nuclear extracts from the ventral
and their respective wild-type littermates. Normalized MeCP2 levels are shown b
n = 4–6 experimental replications).
*p < 0.05, **p < 0.01; unpaired two-tailed t test (G, I, J, and K). All data error bars2013; M€uller et al., 2015). We provide both molecular and phar-
macological evidence for the involvement of Sphk1 and S1P in
anxiety pathways. The clear anxiolytic effects of fingolimod sug-
gest that this pathway provides new targets for anxiety drug
development and demonstrate the possibility of repurposing ex-
isting drugs to anxiety therapy. In this context, a prospective
study described a decrease in anxiety levels in multiple sclerosis
patients upon initiation of fingolimod treatment (Moreau et al.,
2017). Current therapies for anxiety disorders either directly
affect neurotransmitter receptor systems or modulate neuro-
transmitter levels or availability, but their long-term use is limited
by problematic side effects and suboptimal efficacy (Griebel and
Holmes, 2013). Despite keen interest in the development of
mechanistically novel anxiolytic drugs, these have not been
forthcoming over the past two decades (Murrough et al., 2015).
We hope that the anxiety-regulating mechanisms identified
here may provide new avenues to this end.STAR+METHODS
Detailed methods are provided in the online version of this paper
and include the following:
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Figure 6. Acute Knockdown of Importin a5
in the Ventral Hippocampus of Adult Mice
(A) Lentiviral shRNA knockdown of importin a5 by
stereotaxic injections in the ventral hippocampus.
(B–D) Ventral hippocampus-specific targeting re-
sults in the reduction of anxiety-related behaviors
in the open-field test, as shown by the increased
time spent (p < 0.01) in the center area (B and C)
and the higher distance covered (p < 0.05) in the
center (D) by sha5-injected animals compared to
the scramble-injected controls.
(E–G) sha5 mice show increased exploration of the
open arms of an elevated plus maze, as shown by
representative track traces (E), significantly higher
time spent (F), and distance coverage (G) (both
p < 0.05) compared to their scramble-injected lit-
termates (n = 13 Lenti_scramble, n = 9 Lenti_sha5).
(H) AAV-mediated knockdown and rescue of
importin a5 expression by stereotaxic injections
of shRNA alone or in combination with an importin
a5-expressing rescue construct in the ventral
hippocampus.
(I–K) AAV-driven knockdown of importin a5
(AAV5-sha5) in the ventral hippocampus results in
the reduction of anxiety-related behaviors in the
open-field test, as shown by the increased time
spent (p < 0.01) in the center area (I and J) and the
higher distance covered (p < 0.05) in the center
(K). In contrast, the rescued mice (AAV5-sha5 +
importin a5 open reading frame [a5ORF]) do not
show significant differences compared to their
scramble-injected littermates.
(L–N) sha5 knockdown mice show increased
exploration of the open arms of an elevated plus
maze, as shown by representative track traces (L),
significantly higher time spent (M), and distance
coverage in the open arms (N) (both p < 0.05). The
rescued mice (AAV5-sha5 + a5ORF) did not
exhibit differences compared to their scramble-
injected littermates. The mice receiving both the
scramble and the a5 construct (AAV5-scramble +
a5ORF), were not affected in the open field or in
the elevated plus maze. (n = 8 AAV5_scramble,
n = 8 AAV5_sha5, n = 7–8 AAV5-sha5+a5ORF,
n = 10 AAV5-scramble+a5ORF).
*p < 0.05, **p < 0.01; unpaired two-tailed t test
(C, D, F, and G) and one-way ANOVA followed by
Dunnett’s multiple comparisons test (J, K, M, and
N). All data error bars represent mean ± SEM. See
also Figure S5.
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STAR+METHODSKEY RESOURCES TABLEREAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
MECP2-e1 (rabbit) E. Joly lab (Kaddoum et al., 2013) N/A
MECP2-e1+e2 (rabbit) E. Joly lab (Kaddoum et al., 2013) N/A
HDAC3 (rabbit) Abcam RRID:AB_443297
GFP (rabbit) MBL International RRID:AB_10597267
RFP (rabbit) Rockland RRID:AB_2209751
T7 (goat) Abcam RRID:AB_307038
Alexa Fluor 488 secondary antibody (Donkey anti-rabbit) Thermo Fisher Scientific RRID:AB_2556546
Alexa Fluor 546 secondary antibody (Donkey anti-rabbit) Thermo Fisher Scientific RRID:AB_2534016
Alexa Fluor 546 secondary antibody (Donkey anti-goat) Thermo Fisher Scientific RRID:AB_2534103
DAPI (4.6-diamino-2-phenolindol dihydrochloride) Thermo Fisher Scientific RRID:AB_2629482
Bacterial and Virus Strains
pAAV-CaMKII-ArchT-GFP backbone Edward Boyden lab (MIT) Addgene plasmid #37807
pAAV-shRNA-ctrl backbone Hongjun Song lab (Johns Hopkins
U School of Medicine)
Addgene plasmid #85741
AAV5-CaMKII-T7-(human Kpna1 ORF) This paper N/A
AAV5-U6-sh (mouse Kpna1)-Venus This paper N/A
AAV5-U6-sh (Scramble)-Venus This paper N/A
FUGW 3rd gen lentiviral plasmid with hUbC-driven EGFP David Baltimore lab (Caltech) Addgene Plasmid #14883
Lenti-U6-shKpna1-hSyn-3NLS-eRFP Charite´ U Viral Core https://vcf.charite.de/en/
Lenti-U6-shScramble-hSyn-3NLS-eRFP Charite´ U Viral Core https://vcf.charite.de/en/
Chemicals, Peptides, and Recombinant Proteins
FG-7142 Sigma-Aldrich Cat#E006-100MG
PF-543 Cayman Chemicals Cat#17034
Fingolimod (FTY-720) Sigma-Aldrich Cat#SML0700-5MG
Critical Commercial Assays
RNA extraction kit: RNAqueous-Micro Kit Ambion / Life Technologies Cat#AM1931
AAVpro Purification Kit (all serotypes) Takara Bio Cat#6666
Deposited Data
Expression profiling by high throughput sequencing GEO (Gene Expression
Omnibus) database
GSE106546
Experimental Models: Cell Lines
HEK293 ATCC RRID:CVCL_0045
Experimental Models: Organisms/Strains
Mouse / C57BL/6OlaHsd Harlan Israel N/A
Mouse / BALB/c Harlan Israel N/A
Mouse / C57BL/6OlaHsd / Importin a1/ Gabriel et al., 2011; Rother et al.,
2011; Shmidt et al., 2007
N/A
Mouse / C57BL/6OlaHsd / Importin a3/ Gabriel et al., 2011; Rother et al.,
2011; Shmidt et al., 2007
N/A
Mouse / C57BL/6OlaHsd / Importin a4/ Gabriel et al., 2011; Rother et al.,
2011; Shmidt et al., 2007
N/A
Mouse / C57BL/6OlaHsd / Importin a5/ Gabriel et al., 2011; Rother et al.,
2011; Shmidt et al., 2007
N/A
Mouse / C57BL/6OlaHsd / Importin a7/ Gabriel et al., 2011; Rother et al.,
2011; Shmidt et al., 2007
N/A
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REAGENT or RESOURCE SOURCE IDENTIFIER
Oligonucleotides
See Table S3 IDT (Integrated DNA Technologies) N/A
Recombinant DNA
shRNA_Kpna1 used in lenti (GCAACACAGAAGTTTAGGAAA) Metabion International AG, Germany N/A
sh-Scramble used in lenti (TTCGCACCCTACTTCGTGG) Metabion International AG, Germany N/A
shRNA_Kpna1 used in AAV5 (GCAACACAGAAGTTTAGGAAATT) IDT (Integrated DNA Technologies) N/A
sh-Scramble used in AAV5 (TTCGCACCCTACTTCGTGGTT) IDT (Integrated DNA Technologies) N/A
pDEST-hMeCP2-GFP Huda Y. Zoghbi lab (Baylor
College of Medicine)
Addgene plasmid #48078
pCMVTNT-T7-KPNA1 Bryce Paschal lab (University
of Virginia)
Addgene plasmid #26677
pmScarlet-i_C1 Dorus Gadella lab (University
of Amsterdam)
Addgene plasmid #85044
Software and Algorithms
Ethovision XT 10 Noldus RRID:SCR_000441
VideoMot2 TSE Systems RRID:SCR_014334
COLORcation Fainzilber lab (Dagan et al., 2016) N/A
TRANSFAC (TF binding site analysis) geneXplain RRID:SCR_005573
Prism v7 for Windows GraphPad Software, La Jolla,
California, USA
RRID:SCR_002798
Fiji NIH RRID:SCR_002285
IMARIS (v7.7.2) Bitplane AG RRID:SCR_007370
Other
Fluoromount-G (mounting solution) SouthernBiotech Cat#0100-01CONTACT FOR REAGENT AND RESOURCES SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Mike
Fainzilber (mike.fainzilber@weizmann.ac.il).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animal Subjects
All animal procedures were approved by the IACUC of the Weizmann Institute of Science. Importin a single mutants for importin a1,
a3, a4, a5 and a7 were generated by conventional gene deletion strategies (Gabriel et al., 2011; Rother et al., 2011; Shmidt et al.,
2007). C57BL/6 or BALB/c mice were from Harlan (Israel). Mice were kept at 24.0 ± 0.5C in a humidity-controlled room under a
12-h light–dark cycle with free access to food andwater. Experiments were carried out on 2-5months oldmalemice, unless specified
otherwise.
METHOD DETAILS
Pharmacological treatments
All drugs were administered by intraperitoneal injection (I.P.). FG-7142 (Sigma-Aldrich, #E006-100MG) was used as an anxiolytic
drug, and administered as described previously (Evans and Lowry, 2007) at a final concentration of 5 mg/kg body weight 30 min
before behavioral testing. The SphK1 antagonist PF-543 (Cayman Chemicals, #17034) was dissolved in 2% DMSO/PBS 0.01M
and administered at a final dosage of 10mg/kg. Fingolimod (FTY-720, Sigma-Aldrich, #SML0700-5MG) was used as an S1P receptor
agonist, dissolved in saline solution and administered at a final dosage of 0.1 mg/kg, as described (Deogracias et al., 2012).
Hippocampal slice preparation
Hippocampal slice recordings were used to investigate the impact of importin a5 deletion at the circuit level. To do so, 8-10 week-old
mice were deeply anesthetized with isoflurane, followed by decapitation. The brains were removed and the horizontal hippocampal
slices (300-350 mm) were prepared with a Vibratome (Ci 7000 smz, Campden instruments Ltd.) in the ice-cold cutting ACSF solutionCell Reports 25, 3169–3179.e1–e7, December 11, 2018 e2
(215 mM sucrose, 20 mM glucose, 26 mM NaHCO3, 2.5 mM KCl, 1.6 mM NaH2PO4, 1 mM CaCl2, 4 mMMgSO4, 4 mMMgCl2). After
sectioning, the slices were transferred to the ACSF solution (124 mM NaCl, 10 mM glucose, 26 mM NaHCO3, 2.5 mM KCl, 1 mM
NaH2PO4, 2.5 mM CaCl2, 0.65 mM MgSO4) and incubated for 1 - 1.5 hours at room temperature under constant oxygenation.
Electrophysiology
Slices were transferred into an interface recording chamber with constant perfusion of warm (32C) oxygenated ACSF. Input-output
relationship (I/O curve) was assessed by stimulation of the Schaffer collaterals with a custom-made constant current stimulus
isolator; the stimulus intensity varied from 0 to 500 mA, the length of stimulation was 0.1 ms. The field excitatory postsynaptic poten-
tials (fEPSP) were recorded by positioning 3-5MU glass pipette in stratum radiatum of theCA1 hippocampal region. The fEPSPswere
amplified, filtered by AC-coupled amplifier (Grass Instrument Co., West Warwick, RI) with a bandwidth of 0.1 Hz - 3 kHz and acquired
at 10 kHz with a NI-6341 A/D converter (National Instruments, Austin, TX) and WinWCP software (Dr. J. Dempster, University of
Strathclyde).
For the analysis, the I/O curves of the basal synaptic transmission were fitted using Boltzman charge-voltage equation to calculate
the stimulation that produces the half-maximal fEPSP response (half-maximal stimulation intensity): f(I) = (max-min)/(1+exp((I1/2-I)/
s))+min,wheremax &min –maximal andminimal responses, respectively, I1/2 – stimulation that produces 50%of maximal response,
I – stimulation intensity, s – slope of rise. For paired-pulse and LTP experiments, the stimulation current was adjusted to about half-
maximal stimulation intensity. For the paired-pulse protocol, at least 5 consecutive recordings were acquired for each stimulation
interval The LTP was induced by two trains of high-frequency stimulations (HFS, 100 Hz for 1 s) with a 20 s inter-train interval.
The LTP usually lasted for 1.5 hr. Changes of fEPSP were evaluated by measurement of slope between 10% and 90% of the
peak response (linear fit). All data were analyzed in IGOR Pro.6.04 (Wavemetrics, Oregon, USA) using custom-written macros for
normalization, fitting and averaging of data and statistical tests. To quantify the changes in synaptic strength in response to HFS
paradigm, the slopes of the post-stimulation fEPSPs were normalized to the fEPSP slopes of baseline recordings (set at 100%).
One way ANOVA followed by Holm-Sidak post hoc analysis was used for statistical comparisons of mean fEPSP slopes, with a
minimal significance level of p < 0.05. 5-6 slices from different animals were used for each recording.
Lentiviral and AAVs vector design and production
Viral vectors were used for knockdown or re-expression of importin a5, as needed. The Lenti-sha5 vector sequences were selected
by cross-referencing the BiOSETTIA shRNA designer (http://biosettia.com/support/shrna-designer) and the MISSION shRNA
library from Sigma. Briefly, two different short hairpin RNA (shRNA) target sequences from the open reading frame of the mouse im-
portin a5 gene (Kpna1) were cloned into shRNA expression cassettes using BamHI/PacI restriction sites driven by the u6 promoter in
a modified third-generation lentiviral plasmid with hUBC-driven EGFP (FUGW was from the Baltimore lab at Caltech, Addgene
plasmid #14883) with 3x-NLS RFP fluorescent reporter driven under human synapsin (hSyn) promoter. RT-qPCR and western
blot analyses were used to select the most appropriate shRNAs, based on their ability to specifically knockdown importin a5.
AAV5 vectors were used to carry out both knockdown and re-expression experiments with similar viruses. To this end, we cloned a
shRNA target sequence of themouse importin a5 gene (Kpna1) as well as a scramble control sequence into an AAV ITR vector driven
by the u6 promoter with a fluorescent eYFP (Venus) reporter. The re-expression construct was generated by cloning the human im-
portin a5 (Kpna1) sequence under the CaMKII promoter with an addition of a 50prime T7 tag into an AAV ITR vector. Recombinant
AAV5 vectors expressing shRNA and hKpna1 were produced by transfecting HEK293T cells using the AAVpro helper-free systems.
AAV5 viral preparations were purified using the AAVpro Purification Kit (All Serotypes; Takara Bio. Inc., Cat#6666).
Intracerebral injections of lentiviral vectors and AAVs
In order to evaluate the impact of acute knockdown and re-expression of importin a5 on anxiety-related behaviors we performed a
series of stereotaxic injections in adult mice. Nine weeks-old C57BL/6J male mice (Envigo, Israel) received bilateral stereotaxic in-
jections of lentivirus carrying a shRNA targeting the murine form of importin a5/Kpna1 (Lenti-U6-shKpna1-hSyn-3NLS-eRFP, n = 13)
or its scramble control sequence (n = 9) into the ventral hippocampus (1 mL lentivirus per side, 0.1 ml. min1). Similarly, nine weeks-old
C57BL/6J male mice (Envigo, Israel) received bilateral stereotaxic injections of AAV5-u6-shKpna1-Venus (n = 8 mice) or the AAV5-
u6-scramble-Venus (n = 8 mice) into the ventral hippocampus (1 ml per side, 0.1 ml min1). Finally, eight adult mice were used for the
rescue experiment and received a combination of two viruses: 1) one expressing the sha5 targeting themurine importin a5 (AAV5-u6-
shKpna1-Venus) and one expressing the human importin a5/Kpna1 ORF (AAV5-CaMKII-T7-hKpna1ORF). 10 other mice received a
combination of AAV5-u6-scramble-Venus with the AAV5-CaMKII-T7-hKpna1ORF expression construct, solely as a readout of im-
portin a5 gene expression. Mice were anesthetized with isoflurane and placed on a computer-guided stereotaxic apparatus (Angle
Two Stereotaxic Instrument, myNeurolab, LeicaMicrosystems Inc., Bannockburn, IL, USA), which is integrated with the Paxinos and
Franklin mouse brain atlas through a control panel. The viral vectors were delivered using a 2 ml Hamilton syringe connected to a
motorized nano-injector. To allow diffusion of the solution into the brain tissue, the needle was left in place for 5 min before and after
the injection (coordinates, relative to bregma: AP = 3.2 mm, L = ± 3.2 mm, H = 3.8 mm, based on a calibration experiment indi-
cating these coordinates as leading to the ventral hippocampus in C57BL/6 strain). The mice recovered from the surgery for a period
of 3 weeks before behavioral testing. Following behavioral tests, confirmation of the knockdown or rescue of importin a5was done by
RT-qPCR. Animals showing no knockdown were discarded from the analysis. Validation of the injection for the lenti-shKpna1 wase3 Cell Reports 25, 3169–3179.e1–e7, December 11, 2018
done by immunostaining using a rabbit anti-RFP antibody, for the AAV5-shKpna1 versus AAV5-scramble by immunostaining using a
rabbit anti-GFP antibody and for the AAV5 carrying the hKpna1ORF by immunostaining using a goat anti-T7 antibody (see Immuno-
fluorescence method section). The stained slides were screened for fluorescence at the injection sites and representative images
taken. The mice that did not show fluorescent labeling at the aimed injection location were excluded from the data.
RNA expression analysis (RNA-Seq)
We carried out RNA-seq analyses to assess the impact of importin a5 deletion on the hippocampal transcriptome. Total RNA was
extracted from hippocampi dissected from either importin a5 or wild-type animals treated with vehicle or the anxiogenic compound
FG-7142. Intraperitoneal injections of vehicle or drug were done 30 minutes prior to dissection (4 experimental groups, 3 animals per
each group and replicate, 3 replicates of the entire set) using the RNAqueous-Micro Kit (Ambion) according tomanufacturer’s instruc-
tions. Replicates of high RNA integrity (RIN R 7) were processed for RNA-Seq on an Illumina HiSeq (read type: SR60_V4) at the
Crown Institute for Genomics (G-INCPM, Weizmann Institute of Science). Data was analyzed using DESeq software and have
been deposited in NCBI’s Gene Expression Omnibus (GEO) and are accessible through GEO series accession number: GSE106546.
Library Construction and Sequencing
500 ng of total RNA for each sample, from three independent experiments, was processed using the TruSeq RNA sample preparation
Kit v2 protocol (Illumina). Libraries were evaluated by Qubit and TapeStation. Sequencing Libraries were constructed with barcodes
to allow multiplexing of 12 samples on 4 lanes of Illumina HiSeq machine, using the Single-Read 50 protocol (v3). The output was
88.5 million reads per sample. FastQ files for each sample were generated by the usage of Illumina CASAVA-1.8.2 software.
Sequence Data/ Bioinformatics Analysis
Reads for each sample, were aligned independently using TopHat2 (v2.0.10) against the mouse genome (GRCm38). The percentage
of the reads that were aligned uniquely to the genome was 92%. Counting proceeded over genes annotated in RefSeq release
mm10, using HTseq-count (version 0.6.1p1). Only uniquely mapped reads were used to determine the number of reads falling
into each gene (intersection-strict mode). Differential analysis was performed using DESeq package (1.18.0) with the betaPrior, cook-
sCutoff and independentFiltering parameters set to False. Differentially expressed genes, were determined by a p value of < 0.05 and
absolute fold changes > 1.5 and max raw counts > 10. Differential expressed (DE) genes were analyzed through the use of Ingenuity
Pathways Analysis (Ingenuity Systems, https://www.qiagenbioinformatics.com/) to determinemost significantly relevant biological
functions and pathways.
Gene expression analysis by RT-qPCR
Total RNA from mouse brain tissue was extracted using the Ambion RNAqueous-Micro total RNA isolation kit (Life Technologies
Corp.). RNA purity, integrity (RIN > 7) and concentration was determined, and 100 ng of total RNA was then used to synthesize
cDNA using SuperScript III (Invitrogen). RT-qPCR was performed on a ViiA7 System (Applied Biosystems) using PerfeCTa SYBR
Green (Quanta Biosciences, Gaithersburg, USA). Forward/Reverse primers were designed for different exons, and the RNA was
treated with DNase H to avoid false-positives. Amplicon specificity was verified by melting curve analysis. All RT-qPCR reactions
were conducted in technical triplicates and the results were averaged for each sample, normalized to Actb levels and the relevant
reporter genes such as RFP, GFP and T7 for the viruses, and analyzed using the comparative DDCt method (Livak and Schmittgen,
2001). The primers (Mus musculus) that were used are listed in Table S3.
Transcription Factor Binding Site (TFBS) analysis
We assessed possible enrichment of different TFBS in datasets of regulated genes using FMatch (geneXplain) on gene sets with fold
changes of 1.5 or more and their corresponding background sets. Promoter sequences from the importin a5 dataset and a list of
background genes (non-deregulated genes) were scanned from 600 base pairs (bp) upstream to 100 bp downstreamof the predicted
transcription start site for each such gene, and TFBS were identified with TRANSFAC 9. TFBS enrichment in test versus background
sets was assessed by t test with p-value threshold of 0.05.
Immunofluorescence
We used immunofluorescence in order to assess the subcellular localization of MeCP2within neurons in different brain areas. Briefly,
mice were deeply anaesthetized with pentobarbital (100 mg/kg) and transcardially perfused (NaCl for 1 min, followed by 4% para-
formaldehyde/PBS 1x for 10 min). Brains were removed and postfixed for 5 h and cryoprotected in 20% sucrose for another 24 h,
then frozen at 80C before cryostat sectioning (20 mm coronal sections). Slices containing sections of cortex (motor cortex),
hippocampus (both ventral and dorsal) and amygdala were collected in separate sets for immunohistochemistry, so that each set
contained every fifth serial section. Briefly, sectionswere rehydrated, permeabilized (0.1%Triton X-100 PBS1X), blocked (7%normal
donkey serum) and incubated overnight at room temperature with the appropriate primary antibody: Rabbit anti-MECP2-e1 (1:1000
(Kaddoum et al., 2013)), Rabbit anti-GFP (1:4000, MBL International Cat# 598-7), Rabbit-anti-RFP (1:1000, Rockland Cat# 600-401-
379), Goat anti-T7 (1:1000, Abcam ab9138). Sections were subsequently incubated with the secondary antibody: donkey anti-rabbit
(Alexa 488 or Alexa 546) or donkey anti-goat Alexa 546 (1:200, Thermo Fisher Scientific), DAPI (4’,6-diamino-2-phenolindolCell Reports 25, 3169–3179.e1–e7, December 11, 2018 e4
dihydrochloride) counterstaining was performed on all sections, in order to visualize the nucleus and then mounted with
Fluoromount-G (SouthernBiotech, Cat#0100-01).
Subcellular fractionation and western blot
Weperformed subcellular fractionation prior to western blot analysis to test if lack of importin a5 reducesMeCP2 nuclear localization.
Analyses were performed on ventral hippocampus and amygdala as these brain regions have been implicated in anxiety-related be-
haviors. Microdissected tissues were flash frozen in liquid nitrogen before preparation of subcellular fractions using the REAP pro-
tocol (Suzuki et al., 2010). The tissue was dissociated in 400 mL fractionation solution (0.1% NP40, Calbiochem, CA, USA) in PBS
using a glass tissue douncer and 100 mL of it kept as ‘‘input.’’ The remaining 300 mL was centrifuged for 5 min at 500 G in 1.5 mL
microcentrifuge tubes and 200 mL of the supernatant kept as the ‘‘cytosolic fraction.’’ The pellet was resuspended in 400 mL fraction-
ation solution and re-centrifuged for 5min at 500 G before discarding the supernatant, and resuspending the ‘‘nuclear fraction’’ pellet
in 400 mL (ventral hippocampus) or 40 mL (amygdala) TRIS buffer. These nuclear fractions were further processed for western blotting.
Protein concentrations were estimated using the BCA method according to the manufacturer’s protocol. Equal amounts of protein
samples were boiled in 5x Laemmli sample buffer, fractionated by SDS-PAGE and transferred to nitrocellulose membrane using a
Bio-Rad transfer apparatus according to the manufacturer’s protocol. Membranes were incubated for 1 h at room temperature in
blocking solution 5% nonfat milk in TBST (10 mM Tris, pH 8.0, 150 mM NaCl, 0.5% Tween 20). After incubation, the membranes
were washed 3 times (15 minutes each) and incubated with the Rabbit anti-MeCP2 antibody (Kaddoum et al., 2013; 1:4000) and
Rabbit anti-HDAC3 (1:1000; Abcam AB160471) for overnight at 4C. Membranes were washed 4 times for 15 minutes and
incubated with a 1:10000 dilution of HRP-conjugated anti-mouse or anti-rabbit antibodies for 1 h. Membranes were washed 4 times
for 10 minutes in TBST and images were captured with the ECL system (Amersham Biosciences) according to the manufacturer’s
protocols and the signal quantified using the Fiji software (http://fiji.sc).
Image processing, colocalization analysis and isosurface rendering
Images were acquired on an Olympus FV1000 inverted confocal (Olympus, Tokyo) with Fluoview (FV10–ASW 4.1) software. In gen-
eral, brain slices were scanned using camera settings identical for all genotypes in a given experiment. Images were imported into the
Fiji version (http://fiji.sc) of the ImageJ software for threshold subtraction and subsequent analyses (see below).
Colocalization analysis
The nuclear localization of MeCP2was determined by colocalization analyses. Fiji contains a panel of preinstalled plugins including a
procedure for colocalization analysis, designated as ‘‘Colocalization Threshold,’’ which calculates a variety of colocalization param-
eters such as the Mander’s colocalization coefficient (Costes et al., 2004) based on pixel intensity correlation measurements. The
background of both channels (MeCP2 and DAPI) was subtracted. The channels were equalized to the intensity range to compensate
for potential intensity differences between the channels. Then, the ‘‘Colocalization Threshold’’ plugin was run without a region of
interest or mask. Numerical correlation parameters were recorded, as well as the 2D intensity histogram for visualization of the
correlation between the two channels.
Isosurface rendering
For higher resolution analyses of MeCP2 localization we used high-resolution 60x confocal image stacks of areas of interest (ventral
hippocampus, dorsal hippocampus, Amygdala, Cortex M1/M2) labeled for MeCP2 and DAPI and reconstructed them by using the
isosurface rendering plugin of the IMARIS software (version 7.7.2, Bitplane AG).
FRET assays in HEK293 cells
FRET acceptor photobleaching experiments were performed to study the interaction of MeCP2 with importin a5. Briefly, HEK293
cells were grown in 35 mm cell culture plates and transfected with 1) MeCP2-GFP + importin a5-mScarlet-I in separate plasmids
or in the control conditions 2) cytoplasmic-GFP + importin a5-mScarlet-I or 3) PTE (phosphotriesterase)-GFP + importin a5-mScar-
let-I; 12 h prior to the experiment cells were split on 24 mm cover glass coated with poly-L-lysine. Imaging was done in PBS solution
containing calcium and magnesium (Sigma). Experiments were performed on the Olympus FV1000 inverted confocal microscope
described above. GFP was excited with 488 nm laser line and mScarlet-I with 561 nm laser line. The acceptor (mScarlet-I) was
bleached with 561 nm laser at maximal power setting. The FRET efficiency (EFRET,%) was analyzed using the Fiji software and calcu-
lated as EFRET = (Dpost + Dpre)/Dpost x 100 with D being the donor (GFP) fluorescence before (pre) and after (post) acceptor bleaching.
Behavioral profiling
All assays were performed during the ‘‘dark’’ active phase of the diurnal cycle under dim illumination (10lx) unless otherwise stated;
the ventilation system in the test rooms provided a65 dB white noise background. Every daily session of testing started with a 2 hr
habituation period to the test rooms. A recovery period of at least 1 day was provided between the different behavioral assays.
Home-cage locomotion test
Home-cage locomotor activity wasmonitored over 72 consecutive hours using the InfraMot system (TSE Systems, Germany) in order
to investigate possible alterations of basal activity and/or circadian rythms. The system tracks the spatial displacement of body-heat
images (infra-red radiation) over time (Cooper et al., 2012; Neufeld-Cohen et al., 2010). The first 24 h were used as a habituation
phase. The last 48h (2 consecutive dark/light cycles) were analyzed and the corresponding mouse activity calculated.e5 Cell Reports 25, 3169–3179.e1–e7, December 11, 2018
Open field
Motility and anxiety-like behaviors were assayed in the open-field (Cooper et al., 2012; Neufeld-Cohen et al., 2010). The total distance
moved (cm), the time spent (global, center, border; s), center/border ratio, mean speed (cm/s), percentage of time spent moving
versus rest in the different defined area were recorded using VideoMot2 (TSE System, Germany) or Ethovision XT11 (Noldus Infor-
mation Technology, the Netherlands). Open-field was performed under 120lx for the assessment of anxiety-related behaviors or 6lx
for the study of general locomotion. Open-field raw data were further analyzed with COLORcation (Dagan et al., 2016), allowing the
unbiased study of mice activity based on group heat-maps.
Elevated plus maze
The elevated plusmazewas used as a proxy for anxiety and risk-taking behaviors. The elevated plusmaze consists of two open arms
and two enclosed ones connected by a central square. Exploration on the open arms is reduced in high anxiety states while it is
increased in low anxiety states (Walf and Frye, 2007). Mice were placed on the central platform facing one of the ‘‘open’’ arms to
initiate a 5-min test session and the time spent in each arm was measured. The test was performed under 7 lx and 65 dB white noise.
The number of entries into, the time spent/distance on the open arms and the percentage of the open arm entries comparedwith total
number of arm entries are were recorded using the VideoMot2 software (TSE System, Germany) or the Ethovision XT11 software
(Noldus Information Technology, the Netherlands).
Acoustic startle reflex (ASR)
Rodent ASR is a major body muscle contraction response to a loud and abrupt sound. Enhanced ASR is a hallmark of increased fear
and/or sustained anxiety (Koch, 1999). An ASR apparatus (StartleResponse, TSE Systems, Germany) consisting of a sound-atten-
uated, well-ventilated cabinet was used. Sessions started with a 5-min acclimation periodwith backgroundwhite noise (65 dB)main-
tained throughout. During the last 2 minutes of this period an individual activity baseline was recorded. Overall, 32 startle stimuli
(120 dB, 40 ms; inter-trials interval: randomly varying, 12–30 s) were presented; the stimuli presentation was divided into three
‘Blocks’: Blocks 1 and 3 consisted of 6 startle stimuli each, whereas Block 2 consisted of 10 startle stimuli and 10 ‘no stimuli’
(65 dB (A), 40 ms; i.e., equivalent to the background white noise) that were presented in a quasi-random manner. Two indices
were recorded for each of the blocks: (1) RT ASR (ms) = mean reaction time to respond to the startle stimuli (latency to exceed
the individual activity baseline). (2) The average response amplitude produced in response to the startling stimuli, and (3) the latency
to reach the maximal response (ms).
Morris water maze
We studied possible alterations of spatial memory in the Morris water maze. The water maze consisted of a circular tank (120 cm
diameter) with a removable escape platform centered in one of the four maze quadrants. In the testing room, only distal visual-spatial
cues for locating the hidden platform were available. During testing, the tank is filled with 24C water clouded with milk powder.
Acquisition phase. The mice were subjected to 4 trials per day with an inter-trial interval of 10 mins, for 5 consecutive days. In
each trial, the mice were required to find a platform located in one of the four quadrant submerged 1 cm below the water surface.
The escape latency in each trial was recorded up to 90 s. Each mouse was allowed to remain on the platform for 15 s and was
then removed from themaze. If themouse did not escape in the allocated time, it wasmanually placed on the platform for 15 s.Probe
test. Memory was assessed 24 hours after the last trial. The escape platform was removed and mice were allowed to search for it for
1 minute; and the time spent, the swimming distance in the different quadrants of the pool and the time spent (percentage) and the
number of crossing over the virtual platform location was monitored using an automated tracking system (VideoMot2, TSE Systems,
Germany).
Fear conditioning
The fear conditioning paradigm was used to study possible alteration of hippocampal or amygdala-dependent forms of memories. A
computer-controlled fear-conditioning system (TSE Systems, Germany) monitors the procedure while measuring freezing behavior
(i.e., lack of movement except respiration). The test is performed within three days as previously described (Neufeld-Cohen et al.,
2010): 1) Habibuation: on the first day, mice are habituated for 5 min to the fear conditioning chamber, a clear Plexiglas cage
(21 cm 3 20 cm 3 36 cm) with a stainless steel floor grid within a constantly illuminated (250 lx) fear-conditioning housing. 2)
Conditioning: conditioning takes place on day 2 in one 5-min training session. Mice initially explore the context for 2 min. Thereafter,
two pairings of a co-terminating tone [conditioned stimulus (CS): 30 s, 3,000 Hz, pulsed 10 Hz, 80 dB (A)] and shock [unconditioned
stimulus (US): 0.7mA, 2 s, constant current) with a fixed ITI of 60 s. The US is delivered through themetal grid floor. Mice are removed
from this chamber 1 min after the last CS–US pairing. The chamber is cleaned with 10% ethanol before each session. The ventilating
fan of the conditioning box housing provides a constant auditory background noise [white noise, 62 dB(A)]. 3) Testing: Context
dependent memory is tested 24 h after the conditioning by re-exposure to the conditioning box for 5 min without any stimuli. The
Cue dependent memory is tested 1 h after the Context test by exposure to the conditioned [conditioned stimulus (CS): 30 s,
3,000 Hz, pulsed 10 Hz, 80 dB (A)] in different environmental conditions (black Plexiglas box, black floor instead of metal grid, no
illumination, no ventilation noise, cleaning solution: acetic acid 10% instead of alcohol 10%).
Accelerated rotarod
We assessed the integrity of balance and coordination with the ROTOR-ROD system (83x91x61 - SD. Instruments, San Diego). This
test is used to measure motor coordination and balance in mice (Crawley, 2008). Mice were subjected to 3 trials, with 5 min inter-trial
intervals. Rotarod acceleration was set at 20rpm in 240 s. Latency to fall (sec) was recorded and the average of the 3 trials was used
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Wire hanging
The wire hanging test examines motor neuromuscular impairment and motor coordination (Gomez et al., 1997; Rafael et al., 2000).
Forepaws of the tested mouse were allowed to grasp and hold the animal suspended on an elevated metal wire (diameter = 2mm,
length = 90cm) 80 cm above a water-filled tank. Traction was determined as the ability not to drop from the wire and to remain stable
and hanging. The time (sec) until the mouse completely releases its grip was recorded.
Pole test
The pole test assesses basal ganglia-relatedmovement disorders inmice (Matsuura et al., 1997). Briefly, mice are placed head-up on
top of a 50 cm-long horizontal pole (1 cm in diameter). The base of the pole was placed in the home cage. When the pole was flipped
downward, animals orient themselves (turn) and descend the length of the pole back into their home cage. Mice received 2d of
training that consisted of five trials for each session. On the test day, animals received five trials, and time to orient downward TTurn
was recorded. If mouse was not able to turn or fell, a cutoff value of 120 s was attributed.
QUANTIFICATION AND STATISTICAL ANALYSIS
Data collection
No statistical methods were used to pre-determine sample sizes which were similar to those reported in previous works. Data collec-
tion and analysis were performed blind to the conditions of the experiment. All mice were assigned randomly to the different exper-
imental groups.
Statistical analysis
A normality test (Shapiro-Wilk test) was applied to all data before analysis for statistical significance. Datasets which passed the
normality test were subjected to parametric analysis. Analysis of multiple groups was made using the ANOVA method. The choice
between one- or two-way ANOVA was based on the requirements for identification of specific factors’ contribution to statistical dif-
ferences between groups and were followed by the Tukey and the Sidak post hoc analysis tests respectively. For 2-groups analyses,
unpaired Student’s t test was used. Datasets that did not pass the normality test were subjected to nonparametric analysis using the
Kruskal-Wallis test on rank for multiple-group statistical evaluation followed by Dunn’s multiple comparisons test. For 2-groups an-
alyses, the Mann-Whitney test was used. Potential outliers were discarded using the ROUTmethod with a Q (maximum desired false
discovery rate) of 1%. All analyses were performed using GraphPad Prism version 7.00 for Windows (GraphPad Software, La Jolla,
California, USA, https://www.graphpad.com/). The results are expressed as the mean ± standard error of the mean (SEM). All sta-
tistical parameters for specific analyses are reported in the figure legends of the paper. Statistically significant P-values are shown as
*p < 0.05, **p < 0.01, ***p < 0.001 and ****p < 0.0001.
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